Correlation Between Petroleo Brasileiro and SIMCERE PHARMAC

Can any of the company-specific risk be diversified away by investing in both Petroleo Brasileiro and SIMCERE PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Petroleo Brasileiro and SIMCERE PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Petroleo Brasileiro Petrobras and SIMCERE PHARMAC GRP, you can compare the effects of market volatilities on Petroleo Brasileiro and SIMCERE PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Petroleo Brasileiro with a short position of SIMCERE PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Petroleo Brasileiro and SIMCERE PHARMAC.

Diversification Opportunities for Petroleo Brasileiro and SIMCERE PHARMAC

-0.27

Correlation Coefficient

Petroleo Brasileiro  SIMCERE PHARMAC

Very good diversification

The 3 months correlation between Petroleo and SIMCERE is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Petroleo Brasileiro Petrobras and SIMCERE PHARMAC GRP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIMCERE PHARMAC GRP and Petroleo Brasileiro is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Petroleo Brasileiro Petrobras are associated (or correlated) with SIMCERE PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIMCERE PHARMAC GRP has no effect on the direction of Petroleo Brasileiro i.e., Petroleo Brasileiro and SIMCERE PHARMAC go up and down completely randomly.

Pair Corralation between Petroleo Brasileiro and SIMCERE PHARMAC

Considering the 90-day investment horizon Petroleo Brasileiro Petrobras is expected to under-perform the SIMCERE PHARMAC. But the stock apears to be less risky and, when comparing its historical volatility, Petroleo Brasileiro Petrobras is 1.12 times less risky than SIMCERE PHARMAC. The stock trades about -0.2 of its potential returns per unit of risk. The SIMCERE PHARMAC GRP is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  81.00  in SIMCERE PHARMAC GRP on September 27, 2024 and sell it today you would earn a total of  0.00  from holding SIMCERE PHARMAC GRP or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Petroleo Brasileiro Petrobras  vs.  SIMCERE PHARMAC GRP

Petroleo Brasileiro

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Petroleo Brasileiro Petrobras has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's fundamental drivers remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

SIMCERE PHARMAC GRP

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in SIMCERE PHARMAC GRP are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, SIMCERE PHARMAC may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Petroleo Brasileiro and SIMCERE PHARMAC

The main advantage of trading using opposite Petroleo Brasileiro and SIMCERE PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Petroleo Brasileiro position performs unexpectedly, SIMCERE PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIMCERE PHARMAC will offset losses from the drop in SIMCERE PHARMAC's long position.

The idea behind Petroleo Brasileiro Petrobras and SIMCERE PHARMAC GRP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.